A shorter radiotherapy (RT) course proved its mettle in early-stage breast cancer in terms of lymphedema risk, without negatively impacting survival outcomes, according to a phase III trial from ...
Adjuvant radiotherapy (RT) for early breast cancer protected against ipsilateral recurrence for 10 years after treatment but not thereafter, according to long-term follow-up from a randomized trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results